Arsenic Trioxide in Acute Promyelocytic Leukemia: Results of Initial US Pilot and Multicenter Trials
We and others have recently confirmed that arsenic trioxide (As2O3) induces a complete remission (CR) in a high proportion of patients
R. P. Warrell, Jr, MD
Advertisement
Articles by R. P. Warrell, Jr, MD
Advertisement
Latest Updated Articles
- Arsenic Trioxide in Acute Promyelocytic Leukemia: Results of Initial US Pilot and Multicenter Trials
Published: March 1st 1999 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
AI-Powered Scout Platform Could Enhance Oncology Decision-Making With Data- and Expert-Driven Insights
2
FDA Grants Interchangeability Designation to 2 Denosumab Biosimilars
3
Novel SSTR-Targeted Alpha Therapy Shows “Encouraging” Activity in GEP-NETs
4
BL-B01D1 Shows Preliminary Efficacy, Favorable Safety in Urothelial Cancer
5
